French consensus regarding precautions during tracheostomy and post-tracheostomy care in the context of COVID-19 pandemic

Philippe Schultz(Hôpital d'Hautepierre), I. Atallah(Centre Hospitalier Universitaire de Grenoble), S. Vergèz(Hôpital Rangueil), J.-B. Morvan(Hôpital d'Instruction des Armées Sainte-Anne), S. Morinière(Centre Hospitalier Universitaire de Tours), S. Bartier(Hôpital Intercommunal de Créteil), E. Babin, Clémence Lacroix(Inserm), Vincent Couloigner(Hôpital Necker-Enfants Malades), Nicolas Fakhry(Aix-Marseille Université), B. Barry(Hôpital Bichat-Claude-Bernard)
European Annals of Otorhinolaryngology Head and Neck Diseases
April 9, 2020
10.1016/j.anorl.2020.04.006
Cited by 76

Related Papers

Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study
|European Archives of Oto-Rhino-Laryngology|2020|2.8k
Clinical and epidemiological characteristics of 1420 European patients with mild‐to‐moderate coronavirus disease 2019
|Journal of Internal Medicine|2020|847
Induction Chemotherapy Followed by Either Chemoradiotherapy or Bioradiotherapy for Larynx Preservation: The TREMPLIN Randomized Phase II Study
|Journal of Clinical Oncology|2013|418
Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised, phase 2 trial
|The Lancet Oncology|2021|231
Features of Mild-to-Moderate COVID-19 Patients With Dysphonia
|Journal of Voice|2020|174